Journal Menu
► Journal MenuJournal Browser
► Journal BrowserSpecial Issue "Mesoporous Materials for Biomedical Application"
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Delivery and Controlled Release".
Deadline for manuscript submissions: 15 August 2023 | Viewed by 500
Special Issue Editor
Interests: nanostructured polymers and composites; mesoporous (bio)materials; metallic particles; functionalized nanoparticles; hybrid micro/nanoparticles with controlled properties; host–guest systems; hybrid magnetic–polymer nanoparticles; porous clay heterostructures; (micro)encapsulation/controlled release of (bio)active substances; sol–gel process; emulsion and microemulsion polymerization
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Mesoporous materials, especially those made of silica, are capturing great interest in the field of nanomedicine, and are intended for both systemic delivery systems and implantable local-delivery devices. In general, mesoporous materials are derived from supramolecular assemblies of surfactants, which template the inorganic component during synthesis. After the surfactant is removed, commonly by pyrolysis or dissolution with the appropriate solvent, the mesoporous matrices are potential drug carriers. Due to their unique pore size, higher surface area and pore volume, mesoporous materials have been widely employed as carriers for controlled drug delivery.
This Special Issue of Pharmaceutics is therefore dedicated to the most recent advances regarding the use of mesoporous materials in the field of biomedical applications.
Given your interesting work on the theme and related disciplines, I personally invite you and your colleagues to contribute either an original research paper or a review, to be published as an invited feature paper to this Special Issue. Research areas may include (but are not limited to) the following: devices based on mesoporous materials related to drugs and drug delivery; controlled-release mesoporous materials for drugs and (bio)pharmaceuticals; nanomedicine; drug targeting; and pharmaceutical formulation.
I look forward to receiving your contributions.
Dr. Cristina Nistor
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- mesoporous materials
- drug delivery
- drug nanocarriers
- mesoporous nanoparticles
- biocompatible materials
- controlled drug delivery formulations
- porosity
